Global Antibodies Market 

Market Size

The global antibodies market size is estimated to be worth USD 183.7 billion in 2024 and is anticipated to reach USD 347.23 billion by 2029 with a CAGR of 11.31% during the forecast period.

Market Drivers

The growing prevalence of various chronic disorders and the escalating advancements in the healthcare industry is contributing to the increased demand for antibodies leading to expanded market revenue growth. The rising applications of antibodies in therapeutic aspects, and their efficacy is enhancing their adoption for research activities is fueling the market growth. The increased investments in the R&D activities by the major market players and growing government support initiatives is enhancing the market growth opportunities. For Instance, according to WHO, noncommunicable diseases are responsible for 74% of all deaths worldwide, which is killing 41 million people each year, and it also stated that the leading noncommunicable diseases are cardiovascular diseases, cancers, respiratory diseases and diabetes. The escalation in the technological advancements in the healthcare industry, and the growing utilisation of antibodies in personalized medicine are creating market growth opportunities.

Market Restraints

The high costs associated with the therapeutic usage of antibodies is becoming the primary hurdle for the market growth especially in the developing nations due to restricted budgets is restraining the market. The presence of stringent regulations for approval and development of new and innovative antibodies acts as significant challenge to the market expansion owing to high complexity. The rising concerns related to side effects such as allergic reactions, and overstimulation of immune system, and arise of tumor lysis syndrome and others are hampering the global market growth rate.

Market Segmentation

Global Antibodies Market – By Product Type

The monoclonal antibodies segment dominated the global antibodies market with prominent share and is expected to maintain the domination during the forecast period. The increased adoption of monoclonal antibodies in the cancer research due to high efficacy in the cancer treatment is enhancing the segment growth revenue. The monoclonal antibodies are highly efficient in identification and development of new medicines for various cancer types is promoting the segment growth opportunities.

The polyclonal antibodies segment is anticipated to record considerable growth during the forecast period. The polyclonal antibodies are widely adopted for research projects which majorly focus on the purification of antigens and examination of tissues and these antibodies are estimated to provide stability, strong affinity, along with good compatibility are few factors escalating the segment growth rate.  

Global Antibodies Market – By Indication

The cancer segment held the most significant share in the antibodies market and is projected to register dominance during the forecast period. The rising prevalence of cancer across the globe and growing geriatric population, and the busy lifestyles of the people is making them low immune and enhancing the chronic disorders among the people which influences positively on demand for the antibodies leading to segment expansion.

The autoimmune diseases segment is estimated to have significant growth during the forecast period. The increased incidence various autoimmune disorders across all aged groups is major factor enhancing the segment growth opportunities.

Global Antibodies Market – By End-User

The hospitals segment accounted with the largest share in the global market and is predicted to register substantial growth during the forecast period. The increased utilisation of antibodies in the treatment of various disease conditions is escalating the segment revenue growth.

The research institutes segment is projected to record prominent growth during the forecast period. The growing expenditure on the research activities worldwide and the enlarging healthcare industry is propelling the segment growth opportunities.

Global Antibodies Market – By Application 

The western blot segment dominated the global antibodies market with considerable growth and is anticipated to have notable growth in the coming years. The increased adoption of western blot due to its accuracy in detection of various important protein entities is augmenting the segment growth.

The ELISA segment is estimated to have significant growth during the forecast period. ELISA is being extensively adopted for disease diagnosis as it helps in detection and measurement of antibodies, antigens, proteins, and glycoproteins in biological samples. This is driving the segment revenue growth.

Regional Analysis

The North American region witnessed significant growth and is projected to register substantial growth during the forecast period with prominent growth rate. The presence of well-established healthcare infrastructure in the region, growing research activities on cancer, stem cells, and biomedical is enhancing the regional market growth opportunities. The presence of major market players across the region, and increasing number of biotechnology and biopharmaceutical firms is escalating the market growth in the region.

The Asia Pacific region is expected to have rapid growth rate during the forecast period leading to notable growth. The growing healthcare expenditure across the regional countries, the increasing collaborations, acquisitions and partnerships among the research institutes and major market players is creating regional market growth opportunities.

Recent Market Developments

·        In July 2023, Bio-Techne Corporation announced the acquisition of Lunaphore. The major aim of the acquisition is to augment the both the companies’ spatial biology leadership in the field of clinical research.

·        In June 2023, Cell Signaling Technology (CST) partnered with Lunaphore. The primary aim of the initiative is to enable the deployment of CST antibodies on the COMET platform by Lunaphore which strengthens the fully-automated spatial biology.